Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
Submitted by
admin
on October 8, 2021 - 10:43am
Source:
Motley Fool
News Tags:
Biogen
Aduhelm
Alzheimer's disease
Headline:
Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
snippet:
The FDA has received reports of potentially serious safety issues with Alzheimer's disease drug Aduhelm.
Problems with the FDA's reporting system that make it hard to determine how frequent the issues are.
The bigger challenge for Biogen is convincing doctors to prescribe Aduhelm.
Do Not Allow Advertisers to Use My Personal information
